Up-regulation of Galectin-9 in vivo results in immunosuppressive effects and prolongs survival of liver allograft in rats
- 1 November 2014
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 162 (1) , 217-222
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Chongqing Municipality (CSTC2012JJA10090)
- Ministry of Education of the People's Republic of China (211153)
- National Natural Science Foundation of China (81170442, 81300364, 30972888, 81270559, 81200329)
This publication has 16 references indexed in Scilit:
- Liver transplantation: Fifty years of experienceWorld Journal of Gastroenterology, 2014
- Evidence of a novel galectin-9-binding membrane glycoprotein ligand on T helper cellsClinical Immunology, 2012
- Mechanisms of Rejection: Current PerspectivesTransplantation, 2012
- Future prospects in immunosuppression for liver transplantationLiver Transplantation, 2011
- Present state of immunosuppressive therapy in liver transplant recipientsLiver Transplantation, 2011
- Antigen-presenting cell function in the tolerogenic liver environmentNature Reviews Immunology, 2010
- Current Status and Future of Liver TransplantationSeminars in Liver Disease, 2010
- The impact of Th17 cells on transplant rejection and the induction of toleranceCurrent Opinion in Organ Transplantation, 2010
- Themes of Liver TransplantationHepatology, 2010
- CD4 T cells in hepatic immune toleranceJournal of Autoimmunity, 2010